Article Text
Letter
Anti-modified citrullinated vimentin (MCV) antibodies in patients with very early synovitis
Statistics from Altmetric.com
Footnotes
-
Funding This work was supported by the Arthritis Research Campaign and the European Community's Sixth Framework Programme (AUTOCURE).
-
Competing interests None.
-
Ethics approval This study was conducted with the approval of the Sandwell and West Birmingham local research ethics committee.
-
Provenance and peer review Not commissioned; externally peer reviewed.